These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C. Eur Heart J; 2001 Aug 01; 22(16):1504-10. PubMed ID: 11482924 [Abstract] [Full Text] [Related]
5. Left atrial and appendage mechanical function after pharmacological or electrical cardioversion in patients with chronic atrial fibrillation: a multicenter, randomized study. Mazzone C, Pandullo C, Scardi S, Salvi R, Miccio M, Cattarini G, Morgera T. Ital Heart J; 2000 Feb 01; 1(2):128-36. PubMed ID: 10730613 [Abstract] [Full Text] [Related]
7. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, Harcombe AA, Linker NJ, Stewart MJ, Davies A, de Belder MA. Am Heart J; 2006 Apr 01; 151(4):863.e1-6. PubMed ID: 16569550 [Abstract] [Full Text] [Related]
11. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study]. Niu F, Huang CX, Jiang H, Yang B, Guo WL, Chen YX, Jin CR, Liu ZM. Zhonghua Yi Xue Za Zhi; 2006 Jan 10; 86(2):121-3. PubMed ID: 16620720 [Abstract] [Full Text] [Related]
12. Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). Atwood JE, Myers JN, Tang XC, Reda DJ, Singh SN, Singh BN. Am Heart J; 2007 Apr 10; 153(4):566-72. PubMed ID: 17383295 [Abstract] [Full Text] [Related]
13. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods. Naegeli B, Straumann E, Bertel O. Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188 [Abstract] [Full Text] [Related]
14. [The effectiveness and safety of d,l-sotalol in the ambulatory treatment of atrial fibrillation and flutter]. Cruz Cruz F, Iturralde Torres P, Picos Bovio E, Medeiros Domingo A, Infante Vázquez O. Arch Inst Cardiol Mex; 1998 Mar 18; 68(6):482-91. PubMed ID: 10365224 [Abstract] [Full Text] [Related]
15. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study. Wozakowska-Kapłon B, Opolski G. Int J Cardiol; 2004 Aug 18; 96(2):171-6. PubMed ID: 15262030 [Abstract] [Full Text] [Related]
16. Effect of sotalol on heart rate, QT interval, and atrial fibrillation cycle length in horses with atrial fibrillation. Decloedt A, Broux B, De Clercq D, Deprez P, Van Steenkiste G, Vera L, Ven S, van Loon G. J Vet Intern Med; 2018 Mar 18; 32(2):815-821. PubMed ID: 29460446 [Abstract] [Full Text] [Related]
18. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. Hohnloser SH, van de Loo A, Baedeker F. J Am Coll Cardiol; 1995 Oct 18; 26(4):852-8. PubMed ID: 7560608 [Abstract] [Full Text] [Related]